本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NovoCure Limited

17.62
+0.86005.13%
盤後17.620.00000.00%19:30 EDT
成交量:90.30萬
成交額:1,574.25萬
市值:20.52億
市盈率:-13.47
高:17.64
開:16.98
低:16.92
收:16.76
52周最高:21.45
52周最低:9.82
股本:1.16億
流通股本:9,642.36萬
量比:0.47
換手率:0.94%
股息:- -
股息率:- -
每股收益(TTM):-1.3082
每股收益(LYR):-1.2221
淨資產收益率:-43.22%
總資產收益率:-9.26%
市淨率:6.07
市盈率(LYR):-14.42

資料載入中...

2025/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/17

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/12/02

重要事件披露

Form 8-K - Current report
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/15

重要事件披露

Form 8-K - Current report
2024/09/03

重要事件披露

Form 8-K - Current report
2024/07/25

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/07/25

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments